Daniel Clegg is a Rheumatology/Immunology physician affiliated with Texas Tech University Health Sciences Center. OpenAlex indexes 149 publications with 10,877 citations (h-index 48); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
50 N Medical Dr
Salt Lake City, UT 841320001
Telephone
801-581-7724Registry record last updated 8 Jul 2007.
Clinical trials
- A Pilot Trial to Assess Low-Intensity Ultrasound in Osteoarthritis
Sponsor: VA Office of Research and Development
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Davol Inc.Program year20241 payment
- Amgen Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
27.8%Proton pump inhibitor15.6%Omeprazole100%Part D<11 patientsCorticosteroid12.2%Prednisone100%Part D<11 patientsAntiparasitic
23.3%Antimalarial23.3%Hydroxychloroquine Sulfate100%Part D≥13 patientsMusculoskeletal
20%Nonsteroidal Anti-inflammatory Drug20%Diclofenac Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1985–2020 per NIH RePORTER. The latest:
- A Pilot Trial to Assess Low-Intensity Ultrasound in Osteoarthritis
Va Salt Lake City Healthcare System
FY2020I01CX000954 - A Pilot Trial to Assess Low-Intensity Ultrasound in Osteoarthritis
Va Salt Lake City Healthcare System
FY2019I01CX000954 - A Pilot Trial to Assess Low-Intensity Ultrasound in Osteoarthritis
Va Salt Lake City Healthcare System
FY2018I01CX000954
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Product of the Physician Global Assessment and body surface area: A simple static measure of psoriasis severity in a longitudinal cohort
Journal of the American Academy of Dermatology
2013 - Limitations in Screening Instruments for Psoriatic Arthritis: A Comparison of Instruments in Patients with Psoriasis
The Journal of Rheumatology
2013 - New Paradigm for Patient-Reported Outcomes Assessment in Foot & Ankle Research: Computerized Adaptive Testing
Foot & Ankle International
2012
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”